MEDICAMENT COMBINE COMPRENANT UN AGONISTE DE TLR7

• 收藏
• 分享

专利权人:

LTD.;SUMITOMO DAINIPPON PHARMA CO.

发明人:

OTA, YOSUKE,OTSUBO, TAKESHI

申请号：

CA3085424

公开号：

CA3085424A1

申请日:

2018.12.20

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

The present invention provides an effector memory T cell inducer or MHC class I inducer that is to be used in combination with an immune checkpoint inhibitor, includes a TLR7 agonist, and is for treating or preventing cancer. The present invention also provides a cancer treatment agent or prevention agent that is to be used in combination with an immune checkpoint inhibitor and includes a TLR7 agonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/